Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02824042
Title Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications

pancreatic adenocarcinoma

fallopian tube cancer

stomach cancer

ovary epithelial cancer

lung non-small cell carcinoma

colon cancer

peritoneum cancer

peritoneal mesothelioma

gastroesophageal adenocarcinoma

cholangiocarcinoma

malignant pleural mesothelioma

thymic carcinoma

triple-receptor negative breast cancer

Therapies

Anetumab ravtansine + Itraconazole

Anetumab ravtansine

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL


No variant requirements are available.